Ligand id: 9806

Name: abrezekimab

Compound class Antibody
International Nonproprietary Names
INN number INN
10745 abrezekimab
CDP7766 | UCB-4144 | UCB4144 | VR-942
Abrezekimab (UCB4144) is an aniti-IL-13 monoclonal being developed as an anti-asthmatic agent. Peptide sequences submitted to the WHO for the proposed INN abrezekimab, match sequences claimed in UCB Pharma patent US8691233, namely sequence IDs 35 and 27 of the preferred antibody named Ab652 in the patent submission [1].
Database Links
Specialist databases
IMGT/mAb-DB 804
Other databases
GtoPdb PubChem SID 354702278
Search PubMed clinical trials abrezekimab
Search PubMed titles abrezekimab
Search PubMed titles/abstracts abrezekimab